Lupus nephritis, associated with skin involvement, mimicking porphyria cutanea tarda


Cite item

Full Text

Abstract

Представлено наблюдение системной красной волчанки с мезангиокапиллярным волчаночным нефритом
и тяжелым поражением кожи, воспроизводящим позднюю кожную порфирию, уступившими иммуносупрес-
сивной терапии.

References

  1. Насонова В.А. Системная красная волчанка. М., 1972. Zecević R.D., Vojvodić D., Ristić B. et al. Skin lesions - an indicator of disease activity in systemic lupus erythematosus? Lupus. 2001; 10(5): 364-367.
  2. Vera-Recabarren M.A., García-Carrasco M., Ramos-Casals M. et al. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients. Br. J. Dermatol. 2010; 162(1): 91-101.
  3. Yell J.A., Mbuagbaw J., Burge S.M. Cutaneous manifestations of systemic lupus erythematosus. Br. J. Dermatol. 1996; 135(3): 355-362.
  4. Callen J.P., Ross L. Subacute cutaneous lupus erythematosus and porphyria cutanea tarda. Report of a case. J. Am. Acad. Dermatol. 1981; 5(3): 269-273.
  5. Morvay M., Hunyadi J., Kószó F. et al. Coexistence of porphyria cutanea tarda and lupus erythematosus. Dermatol. Monatsschr. 1989; 175(1): 20-27.
  6. Bharati A., Kleyn E., Wong G.A. et al. A spectrum of lupus erythematosus from verrucous to systemic, coexisting with two types of porphyria. J. Eur. Acad. Dermatol. Venereol. 2007; 21(7): 1009-1010.
  7. Peitsch W.K., Lorentz K., Goebeler M. et al. Subacute cutaneous lupus erythematosus with bullae associated with porphyria cutanea tarda. J. Dtsch. Dermatol. Ges. 2007; 5(3): 220-222.
  8. Andersson C., Lithner F. Hypertension and renal disease in patients with acute intermittent porphyria. J. Intern. Med. 1994; 236(2): 169-175.
  9. Lee P.K., Abrahams I., Bickers D.R. Porphyria cutanea tarda occurring in a patient with renal failure, systemic lupus erythematosus and chronic hepatitis C infection treated with hemodialysis. Cutis. 1999; 64(4): 237-279.
  10. Gibson G.E., McEvoy M.T. Coexistence of lupus erythematosus and porphyria cutanea tarda in fifteen patients. J. Am. Acad. Dermatol. 1998; 38(4): 569-573.
  11. Allard S.A., Charles P.J., Herrick A.L. et al. Antinuclear antibodies and the diagnosis of systemic lupus erythematosus in patients with acute intermittent porphyria. Ann. Rheum. Dis. 1990; 49(4): 246-248.
  12. van Tuyll van Serooskerken A.M., Habets J.M., Badeloe S. Porphyria cutanea tarda in pre-existent lupus erythematosus - is there an association? Int. J. Dermatol. 2007; 46(Suppl. 3):50-52.
  13. Köstler E., Heinicke H.J., Schneider F. Porphyria cutanea tarda and lupus erythematosus. Z. Gesamte Inn. Med. 1989; 44(17): 527-529.
  14. Murata J., Shimizu T., Tateishi Y. et al. Coexistence of a systemic lupus erythematosus and porphyria cutanea tarda: case successfully improved by avoidance of sun exposure. Int. J. Dermatol. 2006; 45(4): 435-437.
  15. Clemmensen O., Thomsen K. Porphyria cutanea tarda and systemic lupus erythematosus. Arch. Dermatol. 1982; 118(3): 160-162.
  16. Watanabe T., Tsuchida T. Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients. Dermatology. 1995; 190(4): 277-283.
  17. Cardinali C., Caproni M., Bernacchi E. et al. The spectrum of cutaneous manifestations in lupus erythematosus - the Italian experience. Lupus. 2000; 9(6): 417-423.
  18. Walling H.W., Sontheimer R.D. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am. J. Clin. Dermatol. 2009; 10(6): 365-381.
  19. Tebbe B. Clinical course and prognosis of cutaneous lupus erythematosus. Clin. Dermatol. 2004; 22(2): 121-124.
  20. Tebbe B., Mansmann U., Wollina U. et al. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol. 1997; 77(4): 305-308.
  21. Козловская Н.Л., Варшавский В.А., Шилов Е.М. и др. Типы обострений волчаночного нефрита и их прогностическое значение. Тер. арх. 2008; 6: 10-14.
  22. Ponticelli C., Glassock R.J., Moroni G. Induction and maintenance therapy in proliferative lupus nephritis. J. Nephrol. 2010; 23(1): 9-16.
  23. Козловская Н.Л., Варшавский В.А., Шилов Е.М. и др. Клинико-морфологические особенности нефропатии при первичном и вторичном антифосфолипидном синдроме. Тер. арх. 2007; 6: 16-25.
  24. Bahjat F.R., Pine P.R., Reitsma A. et al. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arthritis Rheum. 2008; 58(5): 1433-1444.
  25. Deng G.M., Liu L., Bahjat F.R. et al. Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice. Arthritis Rheum. 2010; 62(7): 2086-2092.
  26. Pisoni C.N., Karim Y., Cuadrado M.J. Mycophenolate mofetil and systemic lupus erythematosus: an overview. Lupus. 2005; 14 Suppl 1: s9-s11.
  27. MMF in Induction Therapy for Active Lupus Nephritis in Mainland China Study Group. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis. Lupus. 2008; 17(7): 622-629.
  28. Radhakrishnan J., Moutzouris D.A., Ginzler E.M. et al. Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis. Kidney Int. 2010; 77(2): 152-160.
  29. Touma Z., Gladman D.D., Urowitz M.B. Mycophenolate mofetil for induction treatment of lupus nephritis: a systematic review and metaanalysis. J Rheumatol. 2010 Oct 15. [Epub ahead of print].
  30. Ginzler E.M., Wofsy D., Isenberg D. et al. ALMS Group. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial. Arthritis Rheum. 2010; 62(1): 211-221.
  31. Schanz S., Ulmer A., Rassner G. et al. Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil. Br. J. Dermatol. 2002; 147(1): 174-178.
  32. Kreuter A., Tomi N.S., Weiner S.M. et al. Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy. Br. J. Dermatol. 2007; 156(6): 1321-1327.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies